Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 874 All time
- Disclosed funding
- $32.9B 789 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SN Produces TRISO nuclear fuel for advanced nuclear reactors | $140M | Series A | Climate tech | United States | Investors | |
| M Provides AI-powered personal finance tools for young adults | $14M | Series A | Fintech | United States | Investors | |
| Y YolandoCompany profile Provides competitive intelligence and Generative Engine Optimization for marketing teams Provides competitive intelligence and Generative Engine Optimization for marketing teams | $8.5M | Series A | AI | Canada | Investors | |
| A AgiledayCompany profile Agileday gives consulting and other services firms one place to connect staffing, project delivery, time reporting and project finances. Agileday gives consulting and other services firms one place to connect staffing, project delivery, time reporting and project finances. | €6.4M | Series A | Enterprise software | Finland | Investors | |
| O Optalysys develops photonic computing technology for AI processing. | £23M | Series A+Series A | Hardware | United Kingdom | Investors | |
| ML Develops AI-powered conversational platform for automotive dealerships | $20M | Series A | Mobility | United States | Investors | |
| C AI-native commercial real estate operations platform | $18M | Series A | Proptech | United States | Investors | |
| N Develops photonic AI inference chips for data centers | $110M | Series A | AI | United States | Investors | |
| OB Octarine BioCompany profile Octarine Bio develops bio-based pigments through precision fermentation for textiles and other industrial applications. Octarine Bio develops bio-based pigments through precision fermentation for textiles and other industrial applications. | €5M | Series A extensionSeries A | Biotech | Denmark | Investors | |
| M Develops and commercializes rare disease therapies using AI | $82M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.